MYB and Miyoshi myopathy: The PROTAC ARV-825 was antiproliferative in a panel of 13 multiple myeloma (MM) cell lines, led to cell cycle arrest and apoptosis, and quickly degraded BRD2 and BRD4 accompanied by suppression of MYB and MYC.